Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab

RS Dalal, AN Ananthakrishnan, MJ Hamilton… - Digestive Diseases and …, 2021 - Springer
A 27-year-old female with a history of hypertension was diagnosed with pan-ulcerative
colitis (UC) after experiencing several weeks of diarrhea, hematochezia, and abdominal …

Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.

RS Dalal, AN Ananthakrishnan… - Digestive Diseases …, 2021 - search.ebscohost.com
Though after the failure of two drug classes surgery was recommended, the patient's
preferences led to pursuit of alternative therapeutic strategies including a partial elemental …

[引用][C] Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab

RS Dalal, AN Ananthakrishnan, MJ Hamilton… - Digestive Diseases and …, 2021 - elibrary.ru

Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab

RS Dalal, AN Ananthakrishnan… - Digestive Diseases …, 2021 - search.proquest.com
A 27-year-old female with a history of hypertension was diagnosed with pan-ulcerative
colitis (UC) after experiencing several weeks of diarrhea, hematochezia, and abdominal …

[引用][C] Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab

RS Dalal, AN Ananthakrishnan… - Digestive diseases …, 2021 - pubmed.ncbi.nlm.nih.gov
Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary
Non-response to Infliximab and Vedolizumab Two Strikes but Not Out: Deep Remission of …

Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.

RS Dalal, AN Ananthakrishnan… - Digestive Diseases …, 2021 - europepmc.org
Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After
Primary Non-response to Infliximab and Vedolizumab. - Abstract - Europe PMC Sign in …